BSE filing, NSE: PARLESOFT. Summary written from the filing by ALFA Finder's alert engine.
Parle Industries Ltd: key numbers
- Share price
- ₹5.54
- Market cap
- ₹27.06 Cr
- Revenue (annual)
- ₹0.64 Cr
- Net profit (annual)
- ₹-0.09 Cr
- P/E (TTM)
- -4.2×Sector 46.5×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Parle Industries Ltd
All →Parle Industries Other Announcement
Parle Industries Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Parle Industries Other Announcement
Parle Industries Limited submitted its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Parle Industries Annual General Meeting
Parle Industries Limited conducted its 43rd Annual General Meeting on September 29, 2026. Shareholders approved the adoption of financial statements and the re-appointment of a director.
Parle Industries Other Announcement
Parle Industries has provided a web-link for its FY 2025-26 Annual Report to shareholders who have not registered their e-mail addresses with the company.
Parle Industries Annual General Meeting
Parle Industries Limited has scheduled its 43rd Annual General Meeting for September 29, 2026. The filing includes relevant book closure dates and e-voting arrangements.
Parle Industries Annual Report
Parle Industries Limited has published its Annual Report for the financial year 2025-2026. The report includes notice for the 43rd Annual General Meeting.
Other merger & restructuring announcements
All →Fermenta Biotech Merger & Restructuring
Fermenta Biotech Limited's board has approved the closure of its inactive wholly-owned subsidiary, Fermenta Biotech (UK) Limited. The move aims to reorganize corporate structure and reduce compliance costs following the UK's exit from the EU.
Thomas Cook (India) Merger & Restructuring
Thomas Cook (India) Ltd announced that the NCLT Mumbai Bench has issued directions regarding its composite scheme of arrangement. The scheme involves demergers and amalgamations with Sterling Holiday Resorts and other group entities.
Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days